Novo Nordisk A/S
DUS:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
DUS:NOV
|
DK |
|
E
|
Electronic Arts Inc
SWB:ERT
|
US |
|
T
|
Takashimaya Co Ltd
DUS:TKM
|
JP |
|
Watsco Inc
F:WC30
|
US |
|
J
|
Jabil Inc
XMUN:JBL
|
US |
|
Takashimaya Co Ltd
F:TKM
|
JP |
|
Vetoquinol SA
F:8JM
|
FR |
|
O
|
Orlen SA
XMUN:PKY1
|
PL |
|
Vimian Group AB
F:0V0
|
SE |
|
Fox Corp
F:FO5B
|
US |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
Fox Corp
LSE:0A0X
|
US |
|
Imugene Ltd
OTC:IUGND
|
AU |
|
F
|
Floor & Decor Holdings Inc
F:1FD
|
US |
|
Medicover AB
LSE:0RPS
|
SE |
|
B
|
Bankinter SA
XMUN:BAKA
|
ES |
|
I
|
Illinois Tool Works Inc
F:ILT
|
US |
|
F
|
Fiserv Inc
DUS:FIV
|
US |
|
G Rent SpA
F:7F3
|
IT |
|
F
|
Flex Ltd
F:FXI
|
SG |
|
T
|
Truist Financial Corp
SWB:BBK
|
US |
|
B
|
Berkshire Hathaway Inc
F:BRYN
|
US |
|
A
|
Alibaba Health Information Technology Ltd
F:TWYA
|
HK |
|
FibroGen Inc
LSE:0IL8
|
US |
Wall St Price Targets
NOV Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for NOV is 43 EUR with a low forecast of 26.5 EUR and a high forecast of 62.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOV's stock price target?
Price Target
43
EUR
According to Wall Street analysts, the average 1-year price target for NOV is 43 EUR with a low forecast of 26.5 EUR and a high forecast of 62.54 EUR.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 2%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is -1%.
